Matthew Plunkett
2016 - CTI BioPharma
In 2016, Matthew Plunkett earned a total compensation of $499.3K as Executive Vice President, Chief Business Officer at CTI BioPharma, a 81% decrease compared to previous year.
Compensation breakdown
| Bonus | $135,000 |
|---|---|
| Salary | $360,000 |
| Other | $4,306 |
| Total | $499,306 |
Plunkett received $360K in salary, accounting for 72% of the total pay in 2016.
Plunkett also received $135K in bonus and $4.3K in other compensation.
Rankings
In 2016, Matthew Plunkett's compensation ranked 11,183rd out of 14,075 executives tracked by ExecPay. In other words, Plunkett earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,183 out of 14,075 | 21st |
Division Manufacturing | 4,342 out of 5,489 | 21st |
Major group Chemicals And Allied Products | 1,549 out of 1,895 | 18th |
Industry group Drugs | 1,250 out of 1,538 | 19th |
Industry Pharmaceutical Preparations | 974 out of 1,176 | 17th |
Source: SEC filing on March 28, 2017.
Plunkett's colleagues
We found five more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2016.
2016
James Bianco
CTI BioPharma
Chief Executive Officer
2016
Jack Singer
CTI BioPharma
Chief Scientific Officer
2016
Bruce Seeley
CTI BioPharma
Secretary
2016
Richard Love
CTI BioPharma
Chief Executive Officer
2016
Louis Bianco
CTI BioPharma